Director Declaration

RNS Number : 5577H

AstraZeneca PLC

18 August 2016

 

18 August 2016 13:00

New external board appointment

Listing Rule LR 9.6.14 R (2)

Graham Chipchase, a Non-Executive Director of AstraZeneca PLC, has been appointed as Chief Executive Officer and a Director of Brambles Limited, a company listed on the Australian Securities Exchange, effective from 2017.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com    

CONTACTS

Media Enquiries
Neil Burrows	UK/Global	[phone]
Vanessa Rhodes	UK/Global	[phone]
Karen Birmingham	UK/Global	[phone]
Rob Skelding	UK/Global	[phone]
Jacob Lund	Sweden	[phone]
Michele Meixell	US	[phone]
Investor Relations
UK
Thomas Kudsk Larsen		[phone]
Craig Marks	Finance, Fixed Income, M&A	[phone]
Nick Stone	Respiratory & Autoimmunity	[phone]
Henry Wheeler	Oncology	[phone]
Christer Gruvris	Infection & Neuroscience	[phone]
US
Lindsey Trickett	Cardiovascular & Metabolic Diseases	[phone]
Mitchell Chan	Oncology	[phone]
Toll-free		[phone]

Adrian Kemp

Company Secretary

AstraZeneca PLC

-ENDS-

 

END

 

 

RDNBVLFFQVFFBBX